326 related articles for article (PubMed ID: 34830213)
1. Hygiene Hypothesis as the Etiology of Kawasaki Disease: Dysregulation of Early B Cell Development.
Lee JK
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830213
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease.
Tang B; Lo HH; Lei C; U KI; Hsiao WW; Guo X; Bai J; Wong VK; Law BY
Phytomedicine; 2020 Apr; 70():153208. PubMed ID: 32283413
[TBL] [Abstract][Full Text] [Related]
3. Single-cell RNA sequencing of peripheral blood mononuclear cells from acute Kawasaki disease patients.
Wang Z; Xie L; Ding G; Song S; Chen L; Li G; Xia M; Han D; Zheng Y; Liu J; Xiao T; Zhang H; Huang Y; Li Y; Huang M
Nat Commun; 2021 Sep; 12(1):5444. PubMed ID: 34521850
[TBL] [Abstract][Full Text] [Related]
4. Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease.
Giordani L; Quaranta MG; Marchesi A; Straface E; Pietraforte D; Villani A; Malorni W; Del Principe D; Viora M
Clin Exp Immunol; 2011 Mar; 163(3):346-53. PubMed ID: 21175593
[TBL] [Abstract][Full Text] [Related]
5. Kawasaki disease may be a hyperimmune reaction of genetically susceptible children to variants of normal environmental flora.
Lee KY; Han JW; Lee JS
Med Hypotheses; 2007; 69(3):642-51. PubMed ID: 17337130
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin, pharmacogenomics, and Kawasaki disease.
Kuo HC; Hsu YW; Wu MS; Chien SC; Liu SF; Chang WC
J Microbiol Immunol Infect; 2016 Feb; 49(1):1-7. PubMed ID: 25556045
[TBL] [Abstract][Full Text] [Related]
7. Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array.
Kuo HC; Chang JC; Kuo HC; Yu HR; Wang CL; Lee CP; Huang LT; Yang KD
Arthritis Rheumatol; 2015 Mar; 67(3):828-36. PubMed ID: 25470559
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.
Ye Q; Gong FQ; Shang SQ; Hu J
Clin Immunol; 2016 Oct; 171():25-31. PubMed ID: 27519954
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and classification of Kawasaki disease.
Sánchez-Manubens J; Bou R; Anton J
J Autoimmun; 2014; 48-49():113-7. PubMed ID: 24485156
[TBL] [Abstract][Full Text] [Related]
10. The genetics of Kawasaki disease.
Onouchi Y
Int J Rheum Dis; 2018 Jan; 21(1):26-30. PubMed ID: 29152908
[TBL] [Abstract][Full Text] [Related]
11. Identification of increased expression of activating Fc receptors and novel findings regarding distinct IgE and IgM receptors in Kawasaki disease.
Chang LS; Ming-Huey Guo M; Lo MH; Kuo HC
Pediatr Res; 2021 Jan; 89(1):191-197. PubMed ID: 31816620
[TBL] [Abstract][Full Text] [Related]
12. [Association study of a functional SNP rs28493229 of ITPKC gene and Kawasaki disease in a Chinese population].
Peng Q; Chen CH; Wu Q; Li B; Liao J; Luo CD; Hu XP; Zheng Z; He HL; Zhang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Dec; 28(6):644-8. PubMed ID: 22161096
[TBL] [Abstract][Full Text] [Related]
13. Changes in Peripheral Blood Neutrophils, Lymphocytes and IL-10 in Children with Kawasaki Disease from Different Age Groups Undergoing Intravenous Immunoglobulin: A Retrospective Study.
Zhang C; Zhang X; Shen J; Lu X; Zhang J; Chen S
Mediators Inflamm; 2020; 2020():5213451. PubMed ID: 33293897
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of children with Kawasaki disease in Istanbul: a retrospective follow-up study.
Kayiran SM; Dindar A; Gurakan B
Clinics (Sao Paulo); 2010; 65(12):1261-5. PubMed ID: 21340213
[TBL] [Abstract][Full Text] [Related]
15. Identification of SAMD9L as a susceptibility locus for intravenous immunoglobulin resistance in Kawasaki disease by genome-wide association analysis.
Kim JJ; Yun SW; Yu JJ; Yoon KL; Lee KY; Kil HR; Kim GB; Han MK; Song MS; Lee HD; Ha KS; Sohn S; Ebata R; Hamada H; Suzuki H; Ito K; Onouchi Y; Hong YM; Jang GY; Lee JK;
Pharmacogenomics J; 2020 Feb; 20(1):80-86. PubMed ID: 30971808
[TBL] [Abstract][Full Text] [Related]
16. A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease.
Amano Y; Akazawa Y; Yasuda J; Yoshino K; Kojima K; Kobayashi N; Matsuzaki S; Nagasaki M; Kawai Y; Minegishi N; Ishida N; Motoki N; Hachiya A; Nakazawa Y; Yamamoto M; Koike K; Takeshita T
Pediatr Rheumatol Online J; 2019 Jul; 17(1):34. PubMed ID: 31269967
[TBL] [Abstract][Full Text] [Related]
17. Assessment of risk factors for Korean children with Kawasaki disease.
Kim JJ; Hong YM; Yun SW; Han MK; Lee KY; Song MS; Lee HD; Kim DS; Sohn S; Ha KS; Hong SJ; Kim KJ; Park IS; Jang GY; Lee JK;
Pediatr Cardiol; 2012 Apr; 33(4):513-20. PubMed ID: 22105492
[TBL] [Abstract][Full Text] [Related]
18. Altered immunoglobulin A and M levels associated with changes in BAFF and APRIL after administration of intravenous immunoglobulin to treat Kawasaki disease.
Doi M; Takeda T; Sakurai Y; Kato J; Hayashi T; Fukuda K; Takase T; Shima M
J Investig Allergol Clin Immunol; 2010; 20(5):413-8. PubMed ID: 20945608
[TBL] [Abstract][Full Text] [Related]
19. Association between P2RY12 Gene Polymorphisms and IVIG Resistance in Kawasaki Patients.
Wang Z; Xu Y; Zhou H; Wang Y; Li W; Lu Z; Jiang Z; Gu X; Zheng H; Zeng L; Huang P; Zhang L; Gu X
Cardiovasc Ther; 2020; 2020():3568608. PubMed ID: 32256707
[TBL] [Abstract][Full Text] [Related]
20. Immunogenetics of Kawasaki disease.
Kumrah R; Vignesh P; Rawat A; Singh S
Clin Rev Allergy Immunol; 2020 Aug; 59(1):122-139. PubMed ID: 32200494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
